25 Grants
This is a chronological listing of grants held by this department, with the most recent listed first. New grants appear in this list quarterly and contribute to the department's Research Profile. The source of grants for this application comes directly from your institution.
-
1.
Laurence Cooper
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
7/20/2012 - 7/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
2.
Laurence Cooper
Innovative T Cell-Targeted Therapy for Ovarian Cancer
9/30/2011 - 10/29/2013
Sponsor: US Department of the Army
-
3.
Vidya Gopalakrishnan
Development of Novel Mouse Models to Study REST Function in Medulloblastoma
9/15/2011 - 8/31/2013
Sponsor: National Institute of Neurological Disorders and Stroke - DHHS - NIH
-
4.
Dennis Hughes
Regulation of Osteosarcoma Metastasis by Notch and Hes 1 Pathway Signaling
9/13/2011 - 7/31/2016
Sponsor: National Cancer Institute - DHHS - NIH
-
5.
Patrick Zweidler-McKay
9/1/2010 - 8/31/2012
Sponsor: National Cancer Institute - DHHS - NIH
-
6.
Dennis Hughes
Preclinical Evaluation of ERBB Family Members as Therapuetic Targets in Osteosarcoma
9/1/2010 - 2/28/2015
Sponsor: National Cancer Institute - DHHS - NIH
-
7.
Laurence Cooper
T-Cell Immunotherapies for Treating Breast Cancer
9/1/2010 - 9/30/2011
Sponsor: US Department of Defense
-
8.
Laurence Cooper
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
8/1/2010 - 5/31/2015
Sponsor: National Cancer Institute - DHHS - NIH
-
9.
Patrick Zweidler-McKay
HES1 mediates cell-specific consequences of Notch signaling in ALL
4/1/2010 - 1/31/2015
Sponsor: National Cancer Institute - DHHS - NIH
-
10.
Laurence Cooper
ARRA-nCounter Prep Station and the Digital Analyzer
1/26/2010 - 1/25/2011
Sponsor: National Center for Research Resources - DHHS - NIH
-
11.
Vidya Gopalakrishnan
Role of REST in Medulloblastoma Genesis
1/1/2010 - 12/31/2013
Sponsor: American Cancer Society, National
-
12.
Laurence Cooper
Bioengineering of cells for in vivo pharmaceutical delivery
12/1/2007 - 11/30/2008
Sponsor: US Defense Advanced Research Projects Agency (DARPA)
-
13.
Laurence Cooper
Adoptive immunotherapy after umbilical cord blood transplant
8/20/2007 - 5/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
14.
Laurence Cooper
Imaging Infused CD19 Specific T Cells in the Tumor
8/17/2007 - 7/31/2010
Sponsor: National Cancer Institute - DHHS - NIH
-
15.
Laurence Cooper
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
6/25/2007 - 5/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
16.
Laurence Cooper
4/15/2007 - 5/15/2011
Sponsor: US Department of Defense
-
17.
Laurence Cooper
Enhancing the efficacy of CD19-specific cord blood-derived T cells
2/5/2007 - 12/31/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
18.
Dennis Hughes
Ras-mediated erbB signaling in Osteosarcoma
9/4/2006 - 5/31/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
19.
Laurence Cooper
Adoptive Immunotherapy with CD19-Specific T Cells After Umbilical Cord Blood Transplant
5/1/2006 - 12/31/2007
Sponsor: National Marrow Donor Program-DHHS-NIH
-
20.
Dean Lee
MHC Restricted Immunotherapeutic Targets in AML
7/1/2005 - 6/30/2009
Sponsor: National Cancer Institute - DHHS - NIH
-
21.
Patrick Zweidler-McKay
Notch-Mediated Apoptosis in Human B Cell Malignancies
9/6/2004 - 12/31/2009
Sponsor: National Cancer Institute - DHHS - NIH
-
22.
Eugenie Kleinerman
Vasculogenesis in Ewing s Sarcoma: Implications for Therapy
12/1/2003 - 7/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
23.
Laura Worth
IL-12 Gene Therapy for Metastatic Osteosarcoma
9/11/2002 - 8/31/2007
Sponsor: National Cancer Institute - DHHS - NIH
-
24.
Eugenie Kleinerman
8/1/1989 - 9/30/2007
Sponsor: American Cancer Society, National
-
25.
Eugenie Kleinerman
Liposome and Polycationic Gene Therapy for Osteosarcoma
8/1/1986 - 12/31/2011
Sponsor: National Cancer Institute - DHHS - NIH
